Pages that link to "Q28570267"
Jump to navigation
Jump to search
The following pages link to Curcumin prevents and reverses murine cardiac hypertrophy (Q28570267):
Displaying 50 items.
- Therapeutic efficacy of TBC3711 in monocrotaline-induced pulmonary hypertension (Q21284417) (← links)
- Epigenetic associations in relation to cardiovascular prevention and therapeutics (Q26771428) (← links)
- A perspective on dietary phytochemicals and cancer chemoprevention: oxidative stress, nrf2, and epigenomics (Q26852571) (← links)
- Cyclin-dependent kinase-9 is a component of the p300/GATA4 complex required for phenylephrine-induced hypertrophy in cardiomyocytes (Q28565260) (← links)
- Targeted expression of receptor-associated late transducer inhibits maladaptive hypertrophy via blocking epidermal growth factor receptor signaling (Q28573220) (← links)
- Temperature-dependent spectroscopic evidences of curcumin in aqueous medium: a mechanistic study of its solubility and stability (Q30579018) (← links)
- Curcumin inhibits ACTH- and angiotensin II-stimulated cortisol secretion and Ca(v)3.2 current (Q33783283) (← links)
- Cancer chemoprevention by dietary polyphenols: promising role for epigenetics (Q34279875) (← links)
- Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? Evidence from a meta-analysis (Q34362340) (← links)
- Inhibition by curcumin of multiple sites of the transforming growth factor-beta1 signalling pathway ameliorates the progression of liver fibrosis induced by carbon tetrachloride in rats (Q34414756) (← links)
- Epigenetic targets of bioactive dietary components for cancer prevention and therapy (Q34508252) (← links)
- Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases (Q34594807) (← links)
- Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets (Q34602448) (← links)
- Curcumin reduces angiotensin II-mediated cardiomyocyte growth via LOX-1 inhibition (Q34619101) (← links)
- Breast cancer phenotypes regulated by tissue factor-factor VII pathway: Possible therapeutic targets (Q34657739) (← links)
- Curcumin suppresses transforming growth factor-β1-induced cardiac fibroblast differentiation via inhibition of Smad-2 and p38 MAPK signaling pathways (Q34676424) (← links)
- Curcumin inhibits bTREK-1 K+ channels and stimulates cortisol secretion from adrenocortical cells (Q34769427) (← links)
- Chromatin remodeling in cardiovascular development and physiology (Q34814306) (← links)
- Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals (Q35129349) (← links)
- Cellular repressor of E1A-stimulated genes attenuates cardiac hypertrophy and fibrosis (Q35832100) (← links)
- Regression of pathological cardiac hypertrophy: signaling pathways and therapeutic targets (Q36281111) (← links)
- The virtue of just enough stress: a molecular model. (Q36519710) (← links)
- Signaling mechanisms of a water soluble curcumin derivative in experimental type 1 diabetes with cardiomyopathy. (Q36698572) (← links)
- Crocetin protects against cardiac hypertrophy by blocking MEK-ERK1/2 signalling pathway (Q37296169) (← links)
- Quantitative control of adaptive cardiac hypertrophy by acetyltransferase p300. (Q37303806) (← links)
- Currying the heart: curcumin and cardioprotection (Q37372188) (← links)
- The protective role of curcumin in cardiovascular diseases (Q37398264) (← links)
- Development of curcumin as an epigenetic agent (Q37769504) (← links)
- Antiapoptotic potential of herbal drugs in cardiovascular disorders: an overview (Q37774361) (← links)
- Cytoprotection by natural and synthetic polyphenols in the heart: novel mechanisms and perspectives (Q37830081) (← links)
- Epigenetic and disease targets by polyphenols (Q38085362) (← links)
- Epigenetic alterations in acute kidney injury (Q38134935) (← links)
- A systematic review and meta-analysis of randomized controlled trials investigating the effects of curcumin on blood lipid levels (Q38153925) (← links)
- Histone deacetylases in cardiac fibrosis: current perspectives for therapy (Q38169839) (← links)
- Chromatin modifications remodel cardiac gene expression (Q38210525) (← links)
- Epigenetic regulation and heart failure (Q38232304) (← links)
- The beneficial role of curcumin on inflammation, diabetes and neurodegenerative disease: A recent update (Q38525317) (← links)
- Epigenetic Regulation of Myocardial Homeostasis, Self-Regeneration and Senescence (Q38539921) (← links)
- Role of Antioxidants for the Treatment of Cardiovascular Diseases: Challenges and Opportunities (Q38559236) (← links)
- Curcumin changes the polarity of tumor-associated microglia and eliminates glioblastoma. (Q38750952) (← links)
- From genetics to epigenetics: new insights into keloid scarring (Q38774686) (← links)
- Dietary phytochemicals as epigenetic modifiers in cancer: Promise and challenges (Q38818485) (← links)
- Phenylephrine-induced cardiac hypertrophy is attenuated by a histone acetylase inhibitor anacardic acid in mice (Q38963028) (← links)
- The double life of cardiac mesenchymal cells: Epimetabolic sensors and therapeutic assets for heart regeneration. (Q38981202) (← links)
- New insights into epigenetic modifications in heart failure (Q38998894) (← links)
- Treatment of cardiovascular pathology with epigenetically active agents: Focus on natural and synthetic inhibitors of DNA methylation and histone deacetylation (Q39010221) (← links)
- Evidence of epigenetic tags in cardiac fibrosis (Q39013526) (← links)
- Epigenetics in Reactive and Reparative Cardiac Fibrogenesis: The Promise of Epigenetic Therapy (Q39018712) (← links)
- Curcumin and its carbocyclic analogs: structure-activity in relation to antioxidant and selected biological properties. (Q39153207) (← links)
- The Impact of Environmental Factors in Influencing Epigenetics Related to Oxidative States in the Cardiovascular System. (Q39368197) (← links)